JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M601595200 on April 19, 2006

J. Biol. Chem., Vol. 281, Issue 25, 17023-17033, June 23, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
281/25/17023    most recent
M601595200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sandur, S. K.
Right arrow Articles by Aggarwal, B. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sandur, S. K.
Right arrow Articles by Aggarwal, B. B.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Plumbagin (5-Hydroxy-2-methyl-1,4-naphthoquinone) Suppresses NF-{kappa}B Activation and NF-{kappa}B-regulated Gene Products Through Modulation of p65 and I{kappa}B{alpha} Kinase Activation, Leading to Potentiation of Apoptosis Induced by Cytokine and Chemotherapeutic Agents*

Santosh K. Sandur, Haruyo Ichikawa, Gautam Sethi, Kwang Seok Ahn, and Bharat B. Aggarwal1

From the Cytokine Research Laboratory, Department of Experimental Therapeutics, Unit 143, the University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030

Plumbagin, derived from the medicinal plant Plumbago zeylanica, modulates cellular proliferation, carcinogenesis, and radioresistance, all known to be regulated by the activation of the transcription factor NF-{kappa}B, suggesting plumbagin might affect the NF-{kappa}B activation pathway. We found that plumbagin inhibited NF-{kappa}B activation induced by TNF, and other carcinogens and inflammatory stimuli (e.g. phorbol 12-myristate 13-acetate, H2O2, cigarette smoke condensate, interleukin-1beta, lipopolysaccharide, and okadaic acid). Plumbagin also suppressed the constitutive NF-{kappa}B activation in certain tumor cells. The suppression of NF-{kappa}B activation correlated with sequential inhibition of the tumor necrosis factor (TNF)-induced activation of I{kappa}B{alpha} kinase, I{kappa}B{alpha} phosphorylation, I{kappa}B{alpha} degradation, p65 phosphorylation, p65 nuclear translocation, and the NF-{kappa}B-dependent reporter gene expression activated by TNF, TNFR1, TRAF2, NIK, IKK-beta, and the p65 subunit of NF-{kappa}B. Plumbagin also suppressed the direct binding of nuclear p65 and recombinant p65 to the DNA, and this binding was reversed by dithiothreitol both in vitro and in vivo. However, plumbagin did not inhibit p65 binding to DNA when cells were transfected with the p65 plasmid containing cysteine 38 mutated to serine. Plumbagin down-regulated the expression of NF-{kappa}B-regulated anti-apoptotic (IAP1, IAP2, Bcl-2, Bcl-xL, cFLIP, Bfl-1/A1, and survivin), proliferative (cyclin D1 and COX-2), and angiogenic (matrix metalloproteinase-9 and vascular endothelial growth factor) gene products. This led to potentiation of apoptosis induced by TNF and paclitaxel and inhibited cell invasion. Overall, our results indicate that plumbagin is a potent inhibitor of the NF-{kappa}B activation pathway that leads to suppression of NF-{kappa}B-regulated gene products. This may explain its cell growth modulatory, anticarcinogenic, and radiosensitizing effects previously described.


Received for publication, February 21, 2006 , and in revised form, April 18, 2006.

* This work was supported by the Clayton Foundation for Research (to B. B. A.), Department of Defense United States Army Breast Cancer Research Program Grant BC010610 (to B. B. A.), National Institutes of Health on lung chemoprevention Grant PO1 CA91844 (to B. B. A.), and National Institutes of Health P50 Head and Neck SPORE Grant P50CA97007 (to B. B. A.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 To whom correspondence should be addressed: 1515 Holcombe Blvd., Houston, TX 77030. Tel.: 713-794-1817; Fax: 713-794-1613; E-mail: aggarwal{at}mdanderson.org.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Cancer Res.Home page
M. K. Pandey, B. Sung, A. B. Kunnumakkara, G. Sethi, M. M. Chaturvedi, and B. B. Aggarwal
Berberine Modifies Cysteine 179 of I{kappa}B{alpha} Kinase, Suppresses Nuclear Factor-{kappa}B-Regulated Antiapoptotic Gene Products, and Potentiates Apoptosis
Cancer Res., July 1, 2008; 68(13): 5370 - 5379.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
G. Sethi, K. S. Ahn, and B. B. Aggarwal
Targeting Nuclear Factor-{kappa}B Activation Pathway by Thymoquinone: Role in Suppression of Antiapoptotic Gene Products and Enhancement of Apoptosis
Mol. Cancer Res., June 1, 2008; 6(6): 1059 - 1070.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
G. Sethi, K. S. Ahn, B. Sung, and B. B. Aggarwal
Pinitol targets nuclear factor-{kappa}B activation pathway leading to inhibition of gene products associated with proliferation, apoptosis, invasion, and angiogenesis
Mol. Cancer Ther., June 1, 2008; 7(6): 1604 - 1614.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
K. A. Thasni, S. Rakesh, G. Rojini, T. Ratheeshkumar, G. Srinivas, and S. Priya
Estrogen-dependent cell signaling and apoptosis in BRCA1-blocked BG1 ovarian cancer cells in response to plumbagin and other chemotherapeutic agents
Ann. Onc., April 1, 2008; 19(4): 696 - 705.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
B. Sung, M. K. Pandey, Y. Nakajima, H. Nishida, T. Konishi, M. M. Chaturvedi, and B. B. Aggarwal
Identification of a novel blocker of I{kappa}B{alpha} kinase activation that enhances apoptosis and inhibits proliferation and invasion by suppressing nuclear factor-{kappa}B
Mol. Cancer Ther., January 1, 2008; 7(1): 191 - 201.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
S. Shukla, C.-P. Wu, K. Nandigama, and S. V. Ambudkar
The naphthoquinones, vitamin K3 and its structural analogue plumbagin, are substrates of the multidrug resistance linked ATP binding cassette drug transporter ABCG2
Mol. Cancer Ther., December 1, 2007; 6(12): 3279 - 3286.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. K. Pandey, B. Sung, K. S. Ahn, A. B. Kunnumakkara, M. M. Chaturvedi, and B. B. Aggarwal
Gambogic acid, a novel ligand for transferrin receptor, potentiates TNF-induced apoptosis through modulation of the nuclear factor-{kappa}B signaling pathway
Blood, November 15, 2007; 110(10): 3517 - 3525.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. K. Pandey, S. K. Sandur, B. Sung, G. Sethi, A. B. Kunnumakkara, and B. B. Aggarwal
Butein, a Tetrahydroxychalcone, Inhibits Nuclear Factor (NF)-{kappa}B and NF-{kappa}B-regulated Gene Expression through Direct Inhibition of I{kappa}B{alpha} Kinase beta on Cysteine 179 Residue
J. Biol. Chem., June 15, 2007; 282(24): 17340 - 17350.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
B. Sung, M. K. Pandey, and B. B. Aggarwal
Fisetin, an Inhibitor of Cyclin-Dependent Kinase 6, Down-Regulates Nuclear Factor-{kappa}B-Regulated Cell Proliferation, Antiapoptotic and Metastatic Gene Products through the Suppression of TAK-1 and Receptor-Interacting Protein-Regulated I{kappa}B{alpha} Kinase Activation
Mol. Pharmacol., June 1, 2007; 71(6): 1703 - 1714.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. K. Manna, R. S. Aggarwal, G. Sethi, B. B. Aggarwal, and G. T. Ramesh
Morin (3,5,7,2',4'-Pentahydroxyflavone) Abolishes Nuclear Factor-{kappa}B Activation Induced by Various Carcinogens and Inflammatory Stimuli, Leading to Suppression of Nuclear Factor-{kappa}B-Regulated Gene Expression and Up-regulation of Apoptosis
Clin. Cancer Res., April 1, 2007; 13(7): 2290 - 2297.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
G. Sethi, K. S. Ahn, M. K. Pandey, and B. B. Aggarwal
Celastrol, a novel triterpene, potentiates TNF-induced apoptosis and suppresses invasion of tumor cells by inhibiting NF-{kappa}B-regulated gene products and TAK1-mediated NF-{kappa}B activation
Blood, April 1, 2007; 109(7): 2727 - 2735.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Kaileh, W. Vanden Berghe, A. Heyerick, J. Horion, J. Piette, C. Libert, D. De Keukeleire, T. Essawi, and G. Haegeman
Withaferin A Strongly Elicits I{kappa}B Kinase beta Hyperphosphorylation Concomitant with Potent Inhibition of Its Kinase Activity
J. Biol. Chem., February 16, 2007; 282(7): 4253 - 4264.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. S. Ahn, G. Sethi, and B. B. Aggarwal
Simvastatin Potentiates TNF-{alpha}-Induced Apoptosis through the Down-Regulation of NF-{kappa}B-Dependent Antiapoptotic Gene Products: Role of I{kappa}B{alpha} Kinase and TGF-beta-Activated Kinase-1
J. Immunol., February 15, 2007; 178(4): 2507 - 2516.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. S. Ahn, G. Sethi, K. Krishnan, and B. B. Aggarwal
{gamma}-Tocotrienol Inhibits Nuclear Factor-{kappa}B Signaling Pathway through Inhibition of Receptor-interacting Protein and TAK1 Leading to Suppression of Antiapoptotic Gene Products and Potentiation of Apoptosis
J. Biol. Chem., January 5, 2007; 282(1): 809 - 820.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
K. S. Ahn, G. Sethi, and B. B. Aggarwal
Embelin, an Inhibitor of X Chromosome-Linked Inhibitor-of-Apoptosis Protein, Blocks Nuclear Factor-{kappa}B (NF-{kappa}B) Signaling Pathway Leading to Suppression of NF-{kappa}B-Regulated Antiapoptotic and Metastatic Gene Products
Mol. Pharmacol., January 1, 2007; 71(1): 209 - 219.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. S. Nair, S. Shishodia, K. S. Ahn, A. B. Kunnumakkara, G. Sethi, and B. B. Aggarwal
Deguelin, an Akt Inhibitor, Suppresses I{kappa}B{alpha} Kinase Activation Leading to Suppression of NF-{kappa}B-Regulated Gene Expression, Potentiation of Apoptosis, and Inhibition of Cellular Invasion
J. Immunol., October 15, 2006; 177(8): 5612 - 5622.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.